Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018)
Charles River Laboratories International (CRL) posted quarterly Liabilities from Discontinued Operations of 1671000.0 for Q1 2018, up 2.77% year-over-year from 1626000.0 in Q1 2017, and down 7.93% quarter-over-quarter from 1815000.0 in Q4 2017.
Charles River Laboratories International (CRL) Liabilities from Discontinued Operations (2009 - 2018) Analysis & Trends
Charles River Laboratories International's Liabilities from Discontinued Operations history runs 9 years deep, the most recent figure standing at 1671000.0 for Q1 2018.
- In Q1 2018, Liabilities from Discontinued Operations rose 2.77% year-over-year to 1671000.0; the TTM figure through Mar 2018 stood at 1671000.0 (up 2.77% YoY), while the FY2017 annual figure was 1815000.0, up 11.83% from the prior year.
- Liabilities from Discontinued Operations for Q1 2018 stood at 1671000.0, down from 1815000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 8357000.0 in Q4 2014, with the low at 1623000.0 in Q4 2016.
- The 5-year median for Liabilities from Discontinued Operations is 1852000.0 (2016), against an average of 3058117.65.
- Peak annual rise in Liabilities from Discontinued Operations reached 332.78% in 2014, while the deepest fall reached 78.5% in 2014.
- Charles River Laboratories International's Liabilities from Discontinued Operations stood at 8357000.0 in 2014, then sank by 77.98% to 1840000.0 in 2015, then fell by 11.79% to 1623000.0 in 2016, then advanced by 11.83% to 1815000.0 in 2017, then declined by 7.93% to 1671000.0 in 2018.
- Business Quant data shows CRL's Liabilities from Discontinued Operations at 1671000.0 in Q1 2018, 1815000.0 in Q4 2017, and 4395000.0 in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Charles River Laboratories International | 14.28 Bn | 14.09 Bn | 452.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 3.48 Mn |
| Mar 31, 2018 | 3.48 Mn |
| Dec 30, 2017 | 3.94 Mn |
| Dec 30, 2017 | 3.94 Mn |
| Sep 30, 2017 | 4.40 Mn |
| Sep 30, 2017 | 4.40 Mn |
| Jul 1, 2017 | 4.85 Mn |
| Jul 1, 2017 | 4.85 Mn |
| Apr 1, 2017 | 5.30 Mn |
| Apr 1, 2017 | 5.30 Mn |
| Dec 31, 2016 | 5.77 Mn |
| Dec 31, 2016 | 5.77 Mn |
| Sep 24, 2016 | 6.21 Mn |
| Sep 24, 2016 | 6.21 Mn |
| Jun 25, 2016 | 7.09 Mn |
| Jun 25, 2016 | 7.09 Mn |
| Mar 26, 2016 | 7.42 Mn |
| Mar 26, 2016 | 7.42 Mn |
| Dec 26, 2015 | 7.89 Mn |
| Dec 26, 2015 | 7.89 Mn |